Prab: CSV import

2025-03-17T18:28:53Z

CSV import

← Older revision		Revision as of 18:28, 17 March 2025
Line 20:		Line 20:
	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-11T04:14:46Z

CSV import

← Older revision		Revision as of 04:14, 11 February 2025
Line 19:		Line 19:
	[[Category:Genetic Disorders]]		[[Category:Genetic Disorders]]
	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-28T02:20:49Z

CSV import

New page

'''Macular Dystrophy''' is a genetic eye disorder that primarily affects the [[macula]], the central part of the [[retina]] responsible for detailed vision and color perception. This condition leads to progressive vision loss and, in some cases, legal blindness. Macular dystrophy is characterized by the accumulation of abnormal deposits, or lipofuscin, in the cells of the macula, which disrupts its normal functioning.

==Causes and Genetics==
Macular dystrophy is primarily caused by mutations in specific genes that are inherited in an autosomal dominant or recessive pattern. The most common genes associated with this condition include the [[ABCA4]] gene and the [[PRPH2]] gene. These genetic mutations lead to the abnormal accumulation of lipofuscin within the macula, causing damage to photoreceptor cells and, consequently, vision impairment.

==Symptoms==
The symptoms of macular dystrophy typically begin in childhood or adolescence but can vary widely in severity. Early signs include difficulty reading, problems with detailed tasks, and distorted or blurred vision. As the condition progresses, individuals may experience a significant reduction in central vision, making tasks such as driving and recognizing faces challenging. However, peripheral vision is usually preserved.

==Diagnosis==
Diagnosis of macular dystrophy involves a comprehensive eye examination, including visual acuity tests, dilated fundus examination, and imaging studies such as optical coherence tomography (OCT) and fluorescein angiography. Genetic testing may also be recommended to identify specific mutations and confirm the diagnosis.

==Treatment==
Currently, there is no cure for macular dystrophy, and treatment focuses on managing symptoms and slowing the progression of the disease. Low vision aids, such as magnifying glasses and specialized electronic devices, can help individuals maximize their remaining vision. In some cases, vitamin supplements may be recommended to support retinal health. Ongoing research is exploring potential treatments, including gene therapy and stem cell therapy, which may offer hope for future advancements.

==Prognosis==
The prognosis for individuals with macular dystrophy varies depending on the type and severity of the condition. While the disease can lead to significant vision loss, most people retain some degree of peripheral vision. Early diagnosis and intervention can help manage symptoms and improve the quality of life.

[[Category:Eye Diseases]]
[[Category:Genetic Disorders]]
{{medicine-stub}}

Macular dystrophy - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import